RLAY CIK: 1812364

Relay Therapeutics, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.98
FY22:
1.02
FY23:
0.77
FY24:
0.81
FY25:
0.58
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.03
FY22:
0.08
FY23:
0.07
FY24:
0.06
FY25:
0.04
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.01
FY22:
1.10
FY23:
0.84
FY24:
0.87
FY25:
0.62

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.02
FY22:
0.06
FY23:
0.03
FY24:
0.05
FY25:
0.03
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
0.09
FY23:
0.06
FY24:
0.04
FY25:
0.03
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.90
FY22:
0.95
FY23:
0.75
FY24:
0.78
FY25:
0.57
Total liabilities & equity
Change from FY21 to FY25
billions USD
FY21:
1.01
FY22:
1.10
FY23:
0.84
FY24:
0.87
FY25:
0.62

All amounts in billions USD Data source:SEC EDGAR